Rigel Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/07/2025 | 1.75 M | $29.40 M | 11.95% | 9.93% |
| MORGAN STANLEY | 02/14/2025 | 1.56 M | $26.26 M | 6.70% | 8.87% |
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 1.15 M | $19.38 M | -25.00% | 6.55% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 1.13 M | $19.02 M | 20.96% | 6.42% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 410,778 | $6.91 M | -7.01% | 2.33% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 402,051 | $6.76 M | 0.60% | 2.28% |
| STATE STREET CORP | 02/14/2025 | 380,515 | $6.40 M | 3.46% | 2.16% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 376,366 | $6.33 M | -10.77% | 2.14% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 299,709 | $5.04 M | 111.14% | 1.70% |
| CM MANAGEMENT, LLC | 02/07/2025 | 242,500 | $4.08 M | -16.38% | 1.38% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/14/2025 | 202,089 | $3.40 M | 13.96% | 1.15% |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 02/11/2025 | 170,100 | $2.86 M | 814.52% | 0.97% |
| NORTHERN TRUST CORP | 02/14/2025 | 145,839 | $2.45 M | 1.10% | 0.83% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 139,128 | $2.34 M | 41.96% | 0.79% |
| NORGES BANK | 02/12/2025 | 129,506 | $2.18 M | 100.00% | 0.74% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 117,957 | $1.98 M | 100.00% | 0.67% |
| DLD ASSET MANAGEMENT, LP | 02/12/2025 | 100,000 | $28,010 | 100.00% | 0.57% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 02/04/2025 | 86,001 | $1.45 M | 15.43% | 0.49% |
| ENSIGN PEAK ADVISORS, INC | 02/14/2025 | 85,878 | $1.44 M | 100.00% | 0.49% |
| ZACKS INVESTMENT MANAGEMENT | 02/13/2025 | 85,423 | $1.44 M | 100.00% | 0.49% |
| UBS OCONNOR LLC | 02/14/2025 | 84,311 | $1.42 M | -27.89% | 0.48% |
| STATE OF WISCONSIN INVESTMENT BOARD | 02/14/2025 | 72,451 | $1.22 M | 151.04% | 0.41% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 70,426 | $1.18 M | 100.00% | 0.40% |
| HRT FINANCIAL LP | 02/14/2025 | 68,191 | $1.15 M | 100.00% | 0.39% |
| SQUAREPOINT OPS LLC | 02/14/2025 | 63,416 | $1.07 M | 40.12% | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 62,870 | $1.06 M | -2.59% | 0.36% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 60,913 | $1.02 M | 100.00% | 0.35% |
| GLOBEFLEX CAPITAL L P | 02/10/2025 | 52,295 | $879,602 | 468.42% | 0.30% |
| TREXQUANT INVESTMENT LP | 02/12/2025 | 44,171 | $742,956 | 100.00% | 0.25% |
| 02/28/2025 | 40,200 | $676,164 | 100.00% | 0.23% | |
| SEGALL BRYANT & HAMILL, LLC | 02/11/2025 | 36,259 | $609,876 | 100.00% | 0.21% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 34,983 | $588,414 | 100.00% | 0.20% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 32,166 | $541,032 | 12.29% | 0.18% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 31,473 | $529,376 | 0.00% | 0.18% |
| LAZARD ASSET MANAGEMENT LLC | 02/14/2025 | 30,840 | $518,000 | 54.11% | 0.18% |
| JUMP FINANCIAL, LLC | 02/13/2025 | 30,035 | $505,189 | 96.50% | 0.17% |
| CITADEL ADVISORS LLC | 02/14/2025 | 28,411 | $477,873 | 100.00% | 0.16% |
| RHUMBLINE ADVISERS | 01/30/2025 | 25,143 | $422,891 | 6.28% | 0.14% |
| 02/10/2025 | 23,700 | $398,634 | 777.78% | 0.13% | |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 23,053 | $387,751 | -79.98% | 0.13% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 21,809 | $366,828 | 70.84% | 0.12% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 21,621 | $363,665 | 100.00% | 0.12% |
| CITADEL ADVISORS LLC | 02/14/2025 | 20,000 | $336,400 | 52.56% | 0.11% |
| NJ STATE EMPLOYEES DEFERRED COMPENSATION PLAN | 02/06/2025 | 20,000 | $336,400 | 0.00% | 0.11% |
| PDT PARTNERS, LLC | 02/14/2025 | 19,829 | $333,524 | -0.43% | 0.11% |
| MAN GROUP PLC | 02/14/2025 | 18,156 | $305,384 | -29.07% | 0.10% |
| MACQUARIE GROUP LTD | 02/14/2025 | 16,207 | $273 | 100.00% | 0.09% |
| VERITION FUND MANAGEMENT LLC | 02/14/2025 | 15,953 | $268,329 | 100.00% | 0.09% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/12/2025 | 15,483 | $260,000 | 100.00% | 0.09% |
| CITIGROUP INC | 02/12/2025 | 14,855 | $249,860 | 11.22% | 0.08% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Rigel Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 137 institutional investors and hedge funds held shares of Rigel Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 1.75 M
MORGAN STANLEY: 1.56 M
ARMISTICE CAPITAL, LLC: 1.15 M
Soleus Capital Management, L.P.: 1.13 M
Assenagon Asset Management S.A.: 410,778
GEODE CAPITAL MANAGEMENT, LLC: 402,051
68.52% of Rigel Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 28.20 M shares in the last 24 months. This purchase volume represents approximately $470.44 M in transactions.